Ledger.Open graph →
SEC Form D · Amendment · filed June 28, 2010

Aegerion Pharmaceuticals, Inc

Offering
$19.8M
Sold
$18.3M
Exemption
—
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

People & firms on this filing (17)

Peter Garrambone · Bridgewater, NJDirectorWilliam Sasiela · Bridgewater, NJExecMichele Ollier · Bridgewater, NJDirectorChristine Pellizzari · Bridgewater, NJExecDavid Scheer · Bridgewater, NJDirectorWilliam H. Lewis · Bridgewater, NJExecAntonio M. Gotto · Bridgewater, NJDirectorJason Fisherman · Bridgewater, NJDirectorMike Janse · Palo Alto, CADirectorMichael Finney · Boston, MAExecAlf Bjorseth · Oslo, Q8ExecBjorge Gretland · Oslo, Q8ExecAl Schuele · Dallas, TXDirectorPaul Vais · Menlo Park, CADirectorKevin Kent · Irvine, CADirectorBruce A. Brown · Kennesaw, GADirectorAlison Kiley · Bridgewater, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗